Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3Completed 3Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 6Rectal Neoplasms 3Pancreatic Neoplasms 1

Interventions

Fluorouracil 155Oxaliplatin 133Leucovorin 124Capecitabine 90Irinotecan 88Radiotherapy 63Bevacizumab 61Cetuximab 38Folfox protocol 25Panitumumab 21Neoadjuvant Therapy 21Surgical Procedures, Operative 19Chemotherapy, Adjuvant 15Radiation 13Floxuridine 13Erlotinib Hydrochloride 13Early Intervention, Educational 13IFL protocol 11Drug Therapy 11Proctectomy 10Magnetic Resonance Spectroscopy 10Counseling 10Surveys and Questionnaires 8Sorafenib 8Psychiatric Rehabilitation 8Gene Expression Profiling 8Radiotherapy, Intensity-Modulated 7Immunohistochemistry 7Gemcitabine 7Celecoxib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Rectal Neoplasms × FOLFOXIRI protocol × Clear all
NCT04380337 2025-02-25

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Stanford University

Phase 2 Completed
38 enrolled 13 charts
Gastrointestinal

Rectal Neoplasms

NCT02217020 2021-04-14

FORTUNE

Sun Yat-sen University

Phase 2 Completed
100 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03443661 2021-02-01

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

ChineseAMS

Phase 2 Completed
50 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡